These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
10. A systematic literature review of the disease burden in patients with recessive dystrophic epidermolysis bullosa. Tang JY; Marinkovich MP; Lucas E; Gorell E; Chiou A; Lu Y; Gillon J; Patel D; Rudin D Orphanet J Rare Dis; 2021 Apr; 16(1):175. PubMed ID: 33849616 [TBL] [Abstract][Full Text] [Related]
11. T-cell activation and bacterial infection in skin wounds of recessive dystrophic epidermolysis bullosa patients. Alexeev V; Huitema L; Phillips T; Cepeda R; de Los Cobos D; Perez RIM; Salas-Garza M; Fajardo-Ramirez OR; Ringpfeil F; Uitto J; Salas-Alanis JC; Igoucheva O Exp Dermatol; 2022 Sep; 31(9):1431-1442. PubMed ID: 35620886 [TBL] [Abstract][Full Text] [Related]
12. Patient-reported outcomes and quality of life in recessive dystrophic epidermolysis bullosa: A global cross-sectional survey. Eng VA; Solis DC; Gorell ES; Choi S; Nazaroff J; Li S; de Souza MP; Murrell DF; Marinkovich MP; Tang JY J Am Acad Dermatol; 2021 Nov; 85(5):1161-1167. PubMed ID: 32199895 [TBL] [Abstract][Full Text] [Related]